Loading stock data…
NTHI
$4.14+0.08 (+1.97%)
Market ClosedLast close May 4
NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
NeOnc Technologies Holdings, Inc. in the Healthcare sector is trading at $4.14. The stock is currently near its 52-week low of $3.20, remaining 49.6% below its 200-day moving average. Technical signals show oversold RSI of 23 and bullish MACD crossover, explaining why NTHI maintains its current current market pressure. The Whystock Score of 25/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Oversold momentum (RSI 23) — potential for technical mean-reversion
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$4.14
Potential Upside
5%
Whystock Fair Value$4.35
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus1 analysts
Mean target$15.00+262.3%
Range$15.00 – $15.00
Fundamentals
NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$123.31M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
354.96%
Volume
Today's trading volume
60,019
Recent News
Insider Buys Additional US$185k In NeOnc Technologies Holdings Stock
Investors who take an interest in NeOnc Technologies Holdings, Inc. ( NASDAQ:NTHI ) should definitely note that the...
With 61% ownership, NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) insiders have a lot riding on the company's future
Key Insights Insiders appear to have a vested interest in NeOnc Technologies Holdings' growth, as seen by their...
AI and biotech take on brain cancer
You can catch Trader Talk on Apple Podcasts, Spotify, YouTube, or wherever you get your podcasts. When a biotech startup lands in a major index just months after its IPO, investors take notice. In this episode of Trader Talk, Kenny Polcari speaks with Amir Heshmatpour, executive chairman and president of NeOnc Technologies (NTHI), about how the company defied a tough market to go public, secure a $50 million partnership in the Middle East, and join the Russell Microcap Index. Heshmatpour explains NeOnc’s focus on intranasal drug delivery for brain cancer, the significance of its partnership with USC’s medical school, and how global clinical trials are expanding the company’s reach. The conversation also includes how AI and quantum computing could transform the biotech industry. It’s a rare behind-the-scenes look at how a small-cap biotech is executing on a global stage. Watch more episodes of Trader Talk here. Trader Talk with Kenny Polcari on Yahoo Finance delivers expert analysis and actionable insights, empowering you to navigate market volatility and secure your financial future. This post was written by Langston Sessoms.
NeOnc Technologies Holdings Insiders Lose Out As Stock Sinks To US$3.72
The recent 22% drop in NeOnc Technologies Holdings, Inc.'s ( NASDAQ:NTHI ) stock could come as a blow to insiders who...